Hempelmann, P., & Höglinger, D. (2021). The glucosylceramide synthase inhibitor PDMP causes lysosomal lipid accumulation and mTOR inactivation. International journal of molecular sciences, 22(13), . https://doi.org/10.3390/ijms22137065
Chicago-Zitierstil (17. Ausg.)Hempelmann, Pia, und Doris Höglinger. "The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and MTOR Inactivation." International Journal of Molecular Sciences 22, no. 13 (2021). https://doi.org/10.3390/ijms22137065.
MLA-Zitierstil (9. Ausg.)Hempelmann, Pia, und Doris Höglinger. "The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and MTOR Inactivation." International Journal of Molecular Sciences, vol. 22, no. 13, 2021, https://doi.org/10.3390/ijms22137065.